Effectdossier · gearchiveerd kwartaal
CMPX
Compass Therapeutics, Inc. · Healthcare · Biotechnology
15Gevolgde houders
0Δ houders
39.02MGehouden aandelen
$136.56MGerapporteerde waarde
+1Nieuwe posities
−1Uitstappen
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +26.4% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | +4 | 68.60M | $150.73M | +11 | −7 |
| Q1 2026 | 79 | +9 | 59.45M | $314.31M | +12 | −3 |
| Q4 2025 | 70 | +2 | 49.56M | $266.12M | +3 | −1 |
| Q3 2025 | 15 | 0 | 39.02M | $136.56M | +1 | −1 |
| Q2 2025 | 12 | +1 | 25.65M | $66.69M | +1 | — |
| Q1 2025 | 8 | +1 | 9.48M | $18.01M | +1 | — |
| Q4 2024 | 7 | -1 | 10.74M | $15.57M | — | −1 |
| Q3 2024 | 7 | -1 | 14.12M | $25.99M | — | −1 |
| Q2 2024 | 8 | — | 14.75M | $14.75M | — | — |
Wie het bezit · Q3 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 7.37M | +14.9% | $25.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 7.37M | +14.9% | $25.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 7.37M | +14.9% | $25.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 7.37M | +14.9% | $25.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 7.37M | +14.9% | $25.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 7.37M | +14.9% | $25.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 7.37M | +14.9% | $25.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | The Vanguard Group ✦ (passief) | 7.06M | +45.6% | $24.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | The Vanguard Group ✦ (passief) | 7.06M | +45.6% | $24.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passief) | 7.06M | +45.6% | $24.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 5.19M | +17.2% | $18.15M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 12 | Fidelity (FMR) ✦ | 4.14M | +0.1% | $14.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 4.14M | +0.1% | $14.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 4.14M | +0.1% | $14.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | JPMorgan Chase ✦ | 4.00M | — | $13.99M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | JPMorgan Chase ✦ | 4.00M | — | $13.99M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | JPMorgan Chase ✦ | 4.00M | — | $13.99M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | JPMorgan Chase ✦ | 4.00M | — | $13.99M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Millennium Management ✦ | 3.24M | +280.4% | $11.33M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (passief) | 3.11M | +57.6% | $10.87M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Geode Capital Management ✦ (passief) | 2.94M | +27.0% | $10.31M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Geode Capital Management ✦ (passief) | 2.94M | +27.0% | $10.31M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | Goldman Sachs Group ✦ | 1.04M | — | $3.64M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Goldman Sachs Group ✦ | 1.04M | — | $3.64M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Wellington Management ✦ | 318.12K | -8.6% | $1.11M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 26 | Wellington Management ✦ | 318.12K | -8.6% | $1.11M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 27 | Wellington Management ✦ | 318.12K | -8.6% | $1.11M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 28 | Citadel Advisors ✦ | 233.27K | Nieuw | $816,449 | 0.0% | New | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 186.95K | — | $654,333 | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 186.95K | — | $654,333 | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 186.95K | — | $654,333 | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Morgan Stanley ✦ | 186.95K | — | $654,333 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Morgan Stanley ✦ | 186.95K | — | $654,333 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Morgan Stanley ✦ | 186.95K | — | $654,333 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Morgan Stanley ✦ | 186.95K | — | $654,333 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Renaissance Technologies ✦ | 79.00K | -64.8% | $276,500 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 59.15K | +22.1% | $207,019 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 59.15K | +22.1% | $207,019 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 59.15K | +22.1% | $207,019 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 59.15K | +22.1% | $207,019 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 41 | T. Rowe Price ✦ | 56.59K | +20.6% | $199,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Citadel Advisors | $816,449 | 0.0% |
Verlaten
| Two Sigma Investments | $41,852 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 199 houders, 172.39M aandelen, $913.59M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q3 2025 ·
Methodologie ·
Verkrijg dit via de API